An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease
Biomarkers for amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) are currently not clinically available for disease diagnosis or analysis of disease progression. If identified, biomarkers could improve patient outcomes by enabling early intervention and assist in the determination of trea...
Main Authors: | Sandra Anne Banack, Rachael Anne Dunlop, Paul Alan Cox |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2020-06-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.200116 |
Similar Items
-
Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
by: Qiao Yi Chen, et al.
Published: (2021-09-01) -
Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
by: Andrew P. Tosolini, et al.
Published: (2017-12-01) -
Small RNA fingerprinting of Alzheimer’s disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles
by: Lesley Cheng, et al.
Published: (2020-01-01) -
Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
by: America Campos, et al.
Published: (2021-09-01) -
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
by: Ida Manna, et al.
Published: (2020-09-01)